Silicon Valley Heavyweights Go All-In on Neo Labs | A Look at the 20 Most Valuable Companies
Silicon Valley's 20 Most Expensive Labs
Articles
Entering the Arena, 2026! Shanghai Crossing Open Mic: 10 Speakers on Record
Turn perspectives into products, and curiosity into action.
What's Behind the AhaCreator 3.0 Update: How AI Is Reshaping the Creator Marketing Industry
Why Is "Influencer Marketing" a Piece of the Pie That Claude Code Can't Cut Out?
Yunqi Capital Invests in Baiyao Technology: AI Virtual Cells Bring Life System Changes into the Computable Era | Yunqi Partners
State Investment Funds Enter the Arena, Opening a New Dimension in Life Science Computing
Qiming View | Qiming Venture Partners' Kan Chen: Leading Two Consecutive Rounds for Ticen Biotech, Firmly Committed to Cutting-Edge Medical Innovation
Qiming Venture Partners remains steadfast in its focus on addressing unmet clinical needs and consistently pursues cutting-edge healthcare innovations with global competitiveness.
Qiming Venture Partners Portfolio Company Tiachen Biologics, a Leader in Allergy and Autoimmune Innovative Drugs in China, Successfully Lists on Hong Kong Exchanges and Clearing Limited
In 2024, Qiming Venture Partners led TianChen Bio's Series B2 round, and then co-led the company's Series C round in 2025.
The Vibe Working Era Begins! Moonshot AI Work Beta Launches, Making AI Your True Work Partner | BlueRun Ventures Family Headlines
Start Vibe Working
The Best Way for Humans and AI Agents to Work Together Hasn't Been Invented Yet | A Conversation with Paperboy
One look, and the Agent gets it.
Yunqi Capital Leads Series A in Puyuan: High-End Testing Equipment Localization Accelerates | Yunqi Partners
Seeing Through to the Core of Materials, Finding Certainty in Manufacturing
Yunqi Capital's Chen Yu: When Technology Paradigms Shift, Long-Term Opportunities Never Arrive Linearly | Yunqi Insights
Seeing the Long Term in Variables